Company Filing History:
8 out of 46 
6 out of 283 
4 out of 62 
Years Active: 1976-2008
Title: **Attila Mandi: Innovator in Pharmaceutical Patents**
Introduction
Attila Mandi is a noteworthy inventor based in Budapest, Hungary, renowned for his significant contributions to the pharmaceutical industry. With a remarkable portfolio of 25 patents, Attila has made profound advancements, particularly in the synthesis of important pharmaceutical compounds.
Latest Patents
Among his recent inventions is a process for the preparation of high purity perindopril and its intermediates, which are crucial in medicinal chemistry. The innovative process relates to the compound 1-{2(S)-[1(S)-(ethoxycarbonyl)butylamino]propionyl}-(3aS,7aS)octahydroindol-2(S)-carboxylic acid, recognized for its role as an ACE inhibitor. This invention also introduces new intermediates of general Formula III, which promise enhanced efficacy and purity in pharmaceutical applications.
Career Highlights
Attila's career is marked by his association with prominent pharmaceutical companies, including Egis Gyógyszergyár and Chinoin Gyógyszer és Vegyészeti Termékek Gyár Rt. His work in these institutions has not only expanded his expertise but also contributed significantly to the field of pharmaceutical innovations.
Collaborations
Throughout his career, Attila has collaborated with esteemed professionals like Jozsef Knoll and Lujza E. Petocz. These partnerships have fostered a collaborative spirit in his work, allowing for shared insights and advancements in drug development.
Conclusion
Attila Mandi's contributions to the field of pharmaceuticals and his innovative patents demonstrate the vital role of inventors in advancing medical science. His work, particularly in the synthesis of high purity medications, showcases the importance of innovation in improving patient care and treatment outcomes.